# Occurrence of Dyskalemia With Treatment for Hypertension

> **NCT05155436** · PHASE4 · COMPLETED · sponsor: **National Heart Foundation of Bangladesh** · enrollment: 1090 (actual)

## Conditions studied

- Hypertension
- Potassium Imbalance

## Interventions

- **DRUG:** Fixed Dose Combination pill of Telmisartan 40mg and Amlodipine 5 mg

## Key facts

- **NCT ID:** NCT05155436
- **Lead sponsor:** National Heart Foundation of Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-15
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-03-31
- **Target enrollment:** 1090 (ACTUAL)
- **Last updated:** 2023-07-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05155436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05155436, "Occurrence of Dyskalemia With Treatment for Hypertension". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT05155436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*